📊 CCEL Key Takeaways
Investment Thesis
Cryo Cell International demonstrates severe financial distress with negative stockholders' equity of -18.6M, indicating the company is technically insolvent. Despite modest positive operating cash flow, the company faces critical liquidity constraints with a current ratio of 0.59x and only 319K in cash against 80.3M in total liabilities. Deteriorating profitability with -7.7% net margins and declining revenue suggests structural business challenges that pose existential risk to the enterprise.
CCEL Strengths
- Positive operating cash flow of 5.5M provides near-term runway despite negative net income
- Free cash flow margin of 16.6% indicates cash-generative operations when excluding capital investments
- Operating income positive at 482.4K shows core business generates some profitability before financing costs
CCEL Risks
- Negative stockholders' equity of -18.6M indicates technical insolvency and severe balance sheet deterioration
- Critical liquidity crisis with current ratio of 0.59x and minimal cash reserves of 319K against substantial liabilities
- Deteriorating earnings with negative net margin of -7.7% and declining revenue; interest coverage ratio of 0.2x indicates inability to service debt from operations
- Liabilities exceed assets by 18.6M, creating existential solvency risk and potential covenant violations
Key Metrics to Watch
- Stockholders' equity trend - critical indicator of solvency recovery or further deterioration
- Operating cash flow sustainability - essential lifeline given negative net income and tight liquidity
- Revenue stabilization and gross profitability improvement - currently insufficient to cover operating costs and debt service
CCEL Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CCEL Profitability Ratios
CCEL vs Default Sector
How CRYO CELL INTERNATIONAL INC compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CCEL Balance Sheet & Liquidity
CCEL 5-Year Financial Trend
5-Year Trend Summary: CRYO CELL INTERNATIONAL INC's revenue has shown modest growth of 3% over the 5-year period. The most recent EPS of $0.05 reflects profitable operations.
CCEL Growth Metrics (YoY)
CCEL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $7.8M | $749.4K | $0.09 |
| Q2 2025 | $7.9M | $355.8K | $0.04 |
| Q1 2025 | $7.9M | $282.9K | $0.03 |
| Q3 2024 | $7.9M | $680.6K | $0.08 |
| Q2 2024 | $7.8M | $221.0K | $0.03 |
| Q1 2024 | $7.8M | $556.2K | $0.07 |
| Q3 2023 | $7.7M | $466.8K | $0.06 |
| Q2 2023 | $7.6M | $221.0K | $0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CCEL Capital Allocation
CCEL SEC Filings
Access official SEC EDGAR filings for CRYO CELL INTERNATIONAL INC (CIK: 0000862692)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CCEL
What is the AI rating for CCEL?
CRYO CELL INTERNATIONAL INC (CCEL) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CCEL's key strengths?
Positive operating cash flow of 5.5M provides near-term runway despite negative net income. Free cash flow margin of 16.6% indicates cash-generative operations when excluding capital investments.
What are the risks of investing in CCEL?
Negative stockholders' equity of -18.6M indicates technical insolvency and severe balance sheet deterioration. Critical liquidity crisis with current ratio of 0.59x and minimal cash reserves of 319K against substantial liabilities.
What is CCEL's revenue and growth?
CRYO CELL INTERNATIONAL INC reported revenue of $31.6M.
Does CCEL pay dividends?
CRYO CELL INTERNATIONAL INC pays dividends, with $3.2M distributed to shareholders in the trailing twelve months.
Where can I find CCEL SEC filings?
Official SEC filings for CRYO CELL INTERNATIONAL INC (CIK: 0000862692) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CCEL's EPS?
CRYO CELL INTERNATIONAL INC has a diluted EPS of $-0.30.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.